Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Endocr Pract. 2020 Dec 14;27(3):228–235. doi: 10.1016/j.eprac.2020.12.004

Figure 2.

Figure 2.

Overall Survival & Disease Specific Survival

Total cancer cohort consisting of first and only cancer (T1, N0, M0 PTC; n = 3280). Overall survival and disease specific survival of total cohort by Charlson Comorbidity Score. Disease specific survival approximates 100% whereas overall survival worsens with increasing Charlson Comorbidity Index Score. DSS is represented by the solid lines and OS is represented by the dashed lines. Each CCS category (0, 1-2, 3+) is represented by a different color.